RANTES upregulation in the Alzheimer's disease brain: a possible neuroprotective role.
about
The Role of Inflammatory Mediators in the Pathogenesis of Alzheimer's DiseaseNeuroinflammation in Alzheimer's disease: chemokines produced by astrocytes and chemokine receptorsAcetaminophen inhibits neuronal inflammation and protects neurons from oxidative stressThe anti-aging effects of LW-AFC via correcting immune dysfunctions in senescence accelerated mouse resistant 1 (SAMR1) strainLW-AFC, a new formula derived from Liuwei Dihuang decoction, ameliorates behavioral and pathological deterioration via modulating the neuroendocrine-immune system in PrP-hAβPPswe/PS1ΔE9 transgenic mice.Differences in abundances of cell-signalling proteins in blood reveal novel biomarkers for early detection of clinical Alzheimer's diseaseProduction of proinflammatory cytokines and chemokines during neuroinflammation: novel roles for estrogen receptors alpha and beta.Plasma proteins predict conversion to dementia from prodromal diseaseChemokine receptor CCR5: from AIDS to atherosclerosisPharmacological induction of CCL5 in vivo prevents gp120-mediated neuronal injury.Effects of the mTOR inhibitor rapamycin on monocyte-secreted chemokinesPigment epithelium-derived factor (PEDF) protects cortical neurons in vitro from oxidant injury by activation of extracellular signal-regulated kinase (ERK) 1/2 and induction of Bcl-2.Mechanisms of dendritic cell trafficking across the blood-brain barrier.Therapeutic Potential of Dental Pulp Stem Cell Secretome for Alzheimer's Disease Treatment: An In Vitro Study.Blood-brain barrier dysfunction as a cause and consequence of Alzheimer's disease.CCL5 and cytokine expression in the rat brain: differential modulation by chronic morphine and morphine withdrawal.Relationship between inflammatory mediators, Aβ levels and ApoE genotype in Alzheimer disease.T Lymphocytes and Inflammatory Mediators in the Interplay between Brain and Blood in Alzheimer's Disease: Potential Pools of New Biomarkers.Chemokines in CNS injury and repair.The impact of neuroimmune changes on development of amyloid pathology; relevance to Alzheimer's disease.The Potential Role of Chemokines in Alzheimer's Disease Pathogenesis.T Cells-Protective or Pathogenic in Alzheimer's Disease?Impact of Cytokines and Chemokines on Alzheimer's Disease Neuropathological Hallmarks.5-Fluorouracil chemotherapy upregulates cytokines and alters hippocampal dendritic complexity in aged mice.Astrocytoma cells upregulate expression of pro-inflammatory cytokines after co-culture with activated peripheral blood mononuclear cells.Immune dysregulation in patients with carpal tunnel syndrome.Constitutive and Stress-induced Expression of CCL5 Machinery in Rodent Retina.RANTES correlates with inflammatory activity and synaptic excitability in multiple sclerosis.Downregulation of Angiotensin II-Induced 12-Lipoxygenase Expression and Cell Proliferation in Vascular Smooth Muscle Cells from Spontaneously Hypertensive Rats by CCL5Pazopanib Reduces Phosphorylated Tau Levels and Alters Astrocytes in a Mouse Model of Tauopathy.Tau and neuroinflammation: What impact for Alzheimer's Disease and Tauopathies?Decreased mRNA expression of CCL5 [RANTES] in Alzheimer's disease blood samples.Angiotensin II inhibits chemokine CCL5 expression in vascular smooth muscle cells from spontaneously hypertensive rats.Longitudinal chemokine profile expression in a blood-brain barrier model from Alzheimer transgenic versus wild-type mice.Thymoquinone increases the expression of neuroprotective proteins while decreasing the expression of pro-inflammatory cytokines and the gene expression NFκB pathway signaling targets in LPS/IFNγ -activated BV-2 microglia cells.Ccl5 Mediates Proper Wiring of Feedforward and Lateral Inhibition Pathways in the Inner RetinaPalm Fruit Bioactives modulate human astrocyte activity in vitro altering the cytokine secretome reducing levels of TNFα, RANTES and IP-10Roles of Microglial and Monocyte Chemokines and Their Receptors in Regulating Alzheimer's Disease-Associated Amyloid-β and Tau PathologiesEffects of Horticultural Therapy on Asian Older Adults: A Randomized Controlled TrialDifferential chemokine expression under the control of peripheral blood mononuclear cells issued from Alzheimer's patients in a human blood brain barrier model
P2860
Q26781815-05E44376-32CA-43D4-BEA2-264D4D62F7F4Q26995483-5C385A46-A192-4CC9-A390-1F1DD5E9F0C2Q28576204-C53BCFC5-8EB5-4637-81C2-66CD8E4DE2EDQ30819335-C0C12D93-090F-41EB-A760-4B7611E17657Q30831806-C223EA66-4074-454A-B04F-2CD24494E077Q33867548-9119C0B9-D6D9-4E79-A7A8-84D44B86EB79Q34157563-90B69313-B908-4245-9199-0010FA7A78B0Q34556953-23B68CAD-AF6D-45CA-B161-89F4FB7E53E9Q34672038-EC7A2B58-AC23-4AE1-A2F4-884ABA186BFFQ35137844-7B26EAD1-BB4A-42C0-8826-1F0C64E680F2Q35278760-13062523-348D-4083-B01F-23E51FF4E0CAQ35592612-8BA9A714-E676-412F-B219-ED0612DC33A5Q35748581-E4F69F97-76F1-4602-802D-3CB3CA3CE8DDQ37043925-A8585210-194D-454A-B062-87570D9DF5B0Q37216153-D1C6FCF6-D714-4B31-AF51-75D46CFD233AQ37227396-5F3387FC-D580-4487-8343-C95DEE86CCA5Q37560084-B9ED90BD-69CE-4643-96A2-5FAAF089454FQ37672845-4F293B85-1F18-43BC-A391-6A418406D162Q38018862-974E17DF-AB1E-4810-BFCC-9F09783B3C7DQ38123243-939B1521-316E-486E-932F-3BC50EDDB3D7Q38177234-DA09F437-B06A-44E1-B00E-9A17413A116CQ38469322-A83FA184-E919-4352-BAC8-1328F706CB44Q39186980-4BA9C00C-0147-44C8-99A3-D97551CC8C0AQ39418513-B1D6FD2B-4929-4946-920F-1CD71E332B07Q39508193-61E1A4A4-5CFB-450E-A5E0-3332E01560A2Q41423404-F17EA630-4053-4BBC-9094-A12780274327Q41721870-12997B73-64A5-4DE9-9D27-6204C601B739Q42487076-0DC9855A-3C07-44AD-9121-F5AEE931820EQ42635527-9A3C2894-1D07-4067-874C-6C490F074E98Q47860695-50E26A78-3566-4279-9278-EA16676A958CQ52315334-32714EFD-20D3-49A3-9FF6-491C36E255F7Q53322341-0AEDA459-DECE-46DD-859C-CCCFD7CB0886Q54355810-BA748BF5-9165-49F2-BFD6-FA9A31968CFAQ55380454-3F089E66-2479-45C4-876B-439A9B627E1DQ55686847-4F518FFC-03BE-411E-9424-4DDB3956FBE6Q58122628-BE93A886-042E-4322-BB5E-78B5D5BCAF83Q58608796-EA1B2A82-16D6-485A-AB4E-9B82C2A66F4DQ58780923-00C5EBB2-4D8C-47DB-BD6D-0883F6BD6C66Q58792479-029573A4-6324-42CA-A7AF-44D2100B100FQ58794404-6530E3BA-E7A3-4D4F-B2EA-DB1C7CAADA30
P2860
RANTES upregulation in the Alzheimer's disease brain: a possible neuroprotective role.
description
2008 nî lūn-bûn
@nan
2008 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2008 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2008年の論文
@ja
2008年学术文章
@wuu
2008年学术文章
@zh-cn
2008年学术文章
@zh-hans
2008年学术文章
@zh-my
2008年学术文章
@zh-sg
2008年學術文章
@yue
name
RANTES upregulation in the Alzheimer's disease brain: a possible neuroprotective role.
@ast
RANTES upregulation in the Alzheimer's disease brain: a possible neuroprotective role.
@en
RANTES upregulation in the Alzheimer's disease brain: a possible neuroprotective role.
@nl
type
label
RANTES upregulation in the Alzheimer's disease brain: a possible neuroprotective role.
@ast
RANTES upregulation in the Alzheimer's disease brain: a possible neuroprotective role.
@en
RANTES upregulation in the Alzheimer's disease brain: a possible neuroprotective role.
@nl
prefLabel
RANTES upregulation in the Alzheimer's disease brain: a possible neuroprotective role.
@ast
RANTES upregulation in the Alzheimer's disease brain: a possible neuroprotective role.
@en
RANTES upregulation in the Alzheimer's disease brain: a possible neuroprotective role.
@nl
P2093
P2860
P1476
RANTES upregulation in the Alzheimer's disease brain: a possible neuroprotective role.
@en
P2093
Debjani Tripathy
Lakshmi Thirumangalakudi
Paula Grammas
P2860
P356
10.1016/J.NEUROBIOLAGING.2008.03.009
P577
2008-04-28T00:00:00Z